NCT07041827View on ClinicalTrials.gov

Cardiotoxicity and Other Late Effects After Radiotherapy and Immuno-chemoTherapy in Non-Hodgkin lYmphoma

CompletedOBSERVATIONAL

Enrollment

217

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

October 1, 2022

Study Completion Date

February 1, 2023

Conditions

Non Hodgkin LymphomaDLBCLCardiovascular DiseasesCardiomyopathiesCardiotoxicityMetabolic SyndromeQuality of LifeLate EffectHeart Failure

Interventions

DIAGNOSTIC_TEST

Cardiovascular assessment

A cardiovascular assessment will be performed to screen for (sub)clinical cardiovascular diseases and to compare the prevalences in survivors of non-Hodgkin lymphoma and a control group.

Trial Locations (1)

1066CX

Netherlands Cancer Institute, Amsterdam

All Listed Sponsors

collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

collaborator

Amsterdam UMC, location VUmc

OTHER

lead

The Netherlands Cancer Institute

OTHER

NCT07041827 - Cardiotoxicity and Other Late Effects After Radiotherapy and Immuno-chemoTherapy in Non-Hodgkin lYmphoma | Biotech Hunter | Biotech Hunter